Denise M. Adams, MD

Marjory J. Johnson Chair of Vascular Tumor Translational Research

Medical Director, Hemangioma and Vascular Malformation Program

Fellowship Director, Hematology / Oncology

Professor, UC Department of Pediatrics

Phone 513-636-4266

Fax 513-636-3549


Dr. Denise Adams is the medical director of the Hemangioma and Vascular Malformations Center. She is one of the medical physicians who evaluate patients to identify the proper diagnosis and develop with families an optimal treatment plan. She is trained in hematology/oncology. Dr. Adams obtained her schooling from Georgetown University. She first came to Cincinnati Children’s in 2003, and has strived since that time to provide exemplary care for the children served here within our multidisciplinary team. One of the vascular team’s main priorities has been establishing standards of care for patients with these diagnoses so they can follow outcome measures. Of key interest to Dr. Adams is the improving of the care of patients with kaposiform hemangioendotheliomas (KHE) and other rare vascular tumors. Dr. Adams was awarded the Marjory J. Johnson Chair of Vascular Tumor Translational Research for her impact and leadership in the advancement of knowledge of vascular anomalies and the transformation of care for her patients. Dr. Adams has led one of the first prospective NIH-funded trials for the treatment of complicated vascular anomalies; further studies are in development. Clinical trial summaries can be seen on
MD: Georgetown University School of Medicine, 1988.

Post-Graduate: Georgetown University, 1983.

BSN: Georgetown University, 1982.

View PubMed Publications

Quarmyne MO, Gupta A, Adams DM. Lymphangiosarcoma of the thorax and thoracic vertebrae in a 16-year-old girl. J Clin Oncol. 2012 Oct;30(29):294-8.

Haggstrom AN, Beaumont JL, Lai JS, Adams, DM, Drolet BA, Frieden IJ, Garzon MC, Holland KE, Horii KA, Lucky AW, Mancini AJ, Metry DW, Morel KD, Newell BD, Nopper AJ, Siegel D, Swigonski NL, Cella D, Chamlin SL. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol. 2012 Feb;148(2):197-202.

Fadell MF 2nd, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2011 Aug;41(8):1057-60.

Maugans T, Sheridan RM, Adams D, Gupta A. Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited. Neurosurgery. 2011 Jul;69(1):112-8.

Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011 Dec 1;57(6):1018-24.

Adams DM. Special considerations in vascular anomalies: hematologic management. Clin Plast Surg. 2011 Jan;38(1):153-60.

Duffy KJ, Runge-Samuelson C, Bayer ML, Friedland D, Sulman C, Chun R, Kerschner JE, Metry D, Adams D, Drolet BA. Association of hearing loss with PHACE syndrome. Arch Dermatol. 2010 Dec;146(12):1391-6.

Drolet BA, Chamlin SL, Garzon MC, Adams D, Baselga E, Haggstrom AN, Holland KE, Horii KA, Juern A, Lucky AW, Mancini AJ, McCuaig C, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Frieden IJ. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr. 2010 Nov;157(5):789-94.

Lomenick JP, Reifschneider KL, Lucky AW, Adams D, Azizkhan RG, Woo JG, Backeljauw PF. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009 Mar;145(3):262-6.

Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009 Jan;44(1):125-33.